Scoop has an Ethical Paywall
Licence needed for work use Learn More
 

Kimer Med - Latest News [Page 1]

Kimer Med – One Of The World’s ‘Best And Brightest In Biotech’

Wednesday, 7 August 2024, 11:32 am | Kimer Med

Nelson-based biotech company Kimer Med has been named as one of Fierce Biotech’s 2024 prestigious ‘Fierce 15.’ More >>

Kimer Med, The New Zealand Biotech Leading The Charge Against Viral Disease

Thursday, 1 February 2024, 10:12 am | Kimer Med

Ground-breaking New Zealand biotech start-up, Kimer Med, has kicked off a capital raise to complete pre-clinical studies on its broad-spectrum antivirals, ahead of phase 1 clinical trials. The company has spent the past three years working on the ... More >>

Nelson Biotech Founder, Rick Kiessig, Wins GEN NZ Entrepreneur Of The Year Award

Friday, 27 October 2023, 12:37 pm | Kimer Med

Friday 27 October 2023 - Kimer Med co-founder and CEO, Rick Kiessig, was awarded Entrepreneur of the Year at the GEN NZ 2023 Entrepreneurial Ecosystem Awards held at GridAKL Futures Lab in Auckland last night. The awards recognise individuals and ... More >>

Biotech Firm To Expand Its Antiviral Drug Research In Nelson

Thursday, 24 November 2022, 10:29 am | Kimer Med

Nelson biotech company Kimer Med is expanding into a new laboratory and looking to hire additional staff after signing an agreement with Cawthron Institute this week. The move means Kimer Med will now be doing more of its antiviral research in ... More >>

Biotech Start-up Awarded Callaghan Innovation Project Grant

Thursday, 7 July 2022, 5:18 am | Kimer Med

Nelson biotech start-up Kimer Med has been awarded a 2021-22 Project Grant from Callaghan Innovation. The funding will provide a boost to the company’s antiviral protein development work, by reimbursing $150,000 of its eligible research and development ... More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.